Pfizer Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains
Pfizer Inc. (PFE) shares rose 2.03% to $27.65 on Friday, despite a declining stock market, with the S&P 500 down 0.43% and the Dow Jones down 1.05%. This marks Pfizer's second consecutive day of gains, though it remains 1.04% below its 52-week high of $27.94. Compared to competitors, Pfizer's performance was mixed, as Johnson & Johnson, Eli Lilly, and Abbott Laboratories saw higher gains.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Pfizer Inc. (PFE) rallied 2.03% to $27.65 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.43% to 6,878.88 and Dow Jones Industrial Average falling 1.05% to 48,977.92.
This was the stock's second consecutive day of gains.
Pfizer Inc. closed 1.04% short of its 52-week high of $27.94, which the company reached on February 13th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson (JNJ) rose 2.04% to $248.43, Eli Lilly & Co. (LLY) rose 2.93% to $1,051.99, and Abbott Laboratories (ABT) rose 0.08% to $116.35.
Data source: Dow Jones Market Data, FactSet. Data compiled February 27, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
02-27-26 1636ET
